top of page

Press Releases

May 1, 2023

NexEos Bio Names Dawn Rubel as President, Research and Development

March 28, 2023

Pivot Center: University of Utah researcher, Dr. Gerald Gleich of NexEos Bio recognized for decades-long career studying eosinophils

April 10, 2020

FDA Grants Orphan Drug Designation to NexEos Bio’s Investigational Radioimaging Agent as a Diagnostic for the Management of Eosinophilic Esophagitis

August 9, 2019

NexEos licenses novel University of Utah imaging tech for diagnosing eosinophil-related inflammation

bottom of page